In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide

Melanoma Research

Volumn 14, Issue 3, 2004, Pages 189-196

  Fuggetta, Maria Pia ^a,d   D'Atri, Stefania ^b   Lanzilli, Giulia ^a   Tricarico, Maria ^a   Cannavò, Elda ^b   Zambruno, Giovanna ^b   Falchetti, Roberto ^a   Ravagnan, Giampiero ^c  

^a CNR   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^d Sezione Di Genetica Molecolare   (Italy)

Author keywords

Apoptosis; Melanoma cells; Resveratrol; Temozolomide

Indexed keywords

ANTINEOPLASTIC AGENT; RESVERATROL; TEMOZOLOMIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MELANOMA CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; KERATINOCYTES; MELANOMA; NECROSIS; POLY(ADP-RIBOSE) POLYMERASES; S PHASE; STILBENES; TIME FACTORS;

EID: 3042831126     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000130007.54508.b2     Document Type: Article

References (44)

1. Langcake P, Pryce RJ. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 1976; 9:77-86.
2. Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP. Aryl acetylenes as mechanisms-based inhibitors of cytochrome p450-dependent monooxygenase enzymes. Chem Res Toxicol 1997; 10:91-101.
3. Frémont L. Biological effects of resveratrol. Life Sci 2000; 66:663-673.
4. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997; 61:2103-2110.
5. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolios trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235:207-214.
6. Bertelli AA, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17:1-3.
7. 2. Cancer Res 1999; 59: 2596-2601.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275:218-220.
9. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, et al. Resveratrol inhibits cyclo-oxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998; 273:21875-21882.
10. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000; 59:865-870.
11. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein I. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002; 8:893-903.
12. She QB, Bode AM, Ma WY, Chen NY, Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 2001; 61:1604-1610.
13. Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr Med Chem Anti-Canc Agents 2003; 3:77-93.
14. Holmes-McNary M, Baldwin AS Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res 2000; 60:3477-3483.
15. Gilmore T, Gapuzan ME, Kalaitzidis D, Starczynowski D. Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer. Cancer Lett 2002; 181:1-9.
16. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 2003; 190:157-163.
17. Huncharek M, Caubet JF, McGarry R. Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res 2001; 11:75-81.
18. Darkes MJM, Plosker GL, Jarvis B. Temozolomide. A review of its use in the treatment of malignant gliomas, malignant melanoma and other advanced cancer. Am J Cancer 2002; 1:55-80.
19. 6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 1995; 51:167-223.
20. Gerson BL. Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol 2002; 20:2388-2399.
21. 6-alkylguanine-DNA alkyltransferase and mismatch repair activities on the sensitivity of human melanoma cells to temozolomide, 1,3-bis(2-chloroethyl)1-nitrosourea and cisplatin. J Pharmacol Exp Ther 2003; 304:661-668.
22. 6-benzylguanine and its role in chemotherapy. Clin Cancer Res 1997; 3:837-847.
23. 6-benzylguanine: a comparative study in vitro. Br J Cancer 1996; 73:482-490.
24. 6-alkylguanine-DNA alkyltransferase. Br J Cancer 1996; 74:1030-1036.
25. 6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model. Cancer Chemother Pharmacol 1997; 40:266-272.
26. Modrich P. Strand-specific mismatch repair in mammalian cells. J Biol Chem 1997; 272:24727-24730.
27. Jiricny J, Nyström-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev 2000; 10:157-161.
28. Karran P, Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays 1994; 16:833-839.
29. Golub SH, Hanson DC, Sulit HL, Morton DL, Pellegrino MA, Ferrone S. Comparison of histocompatibility antigens on cultured human tumor cells and fibroblasts by quantitative antibody absorption and sensitivity to cell-mediated cytotoxicity. J Natl Cancer Inst 1976; 56:167-170.
30. Alvino E, Marra G, Pagani E, Falcinelli S, Pepponi R, Perrera C, et al. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma. J Invest Dermatol 2002; 118:79-86.
31. Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Melchiori A, Giannetti A, et al. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alfa v beta 6 heterodimer in normal human keratinocytes: implication for wound healing. J Cell Biol 1995; 129:853-865.
32. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119:203-210.
33. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271-279.
34. Zamai L, Falcieri E, Marhefka G, Vitale M. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 1996; 23:303-311.
35. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53: 3976-3985.
36. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001; 7:1466-1473.
37. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ, Argiles JM. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 1999; 254:739-743.
38. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998; 421:277-279.
39. Sun NJ, Woo SH, Cassady JM, Snapka RM. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 1998; 61:362-366.
40. She QB, Ma WY, Wang M, Kaji A, Ho CT, Dong Z. Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved. Oncogene 2003; 22:2143-2150.
41. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, et al. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 2001; 15:1613-1615.
42. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers signaling-dependent apoptosis in human tumor cells. Blood 1998; 92:996-1002.
43. Quinones A, Dobberstein KU, Rainov N. The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. Life Sci 2003; 72:2975-2992.
44. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, et al. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 2000; 7:834-842.